Healthy Volunteer Research Study
Researchers at The National Institute of Allergy and Infectious Diseases are conducting a study to learn more about an investigational flu vaccine.
Fast Facts
Have Not Received the Flu Vaccine Within the Last Few Years
Healthy Adults Ages 18-50
Compensation Provided
Conducted in Bethesda, MD
Study Background
Researchers at The National Institute of Allergy and Infectious Diseases (NIAID) are conducting a research study of an investigational vaccine that targets influenza (flu).
During this study, we will investigate the safety and tolerability of the investigational product and also study your body’s immune response.
If you’re eligible to participate, you will receive the investigational product two times, you will have 15-18 scheduled clinic visits over a period of 40 weeks. Participants will not get flu infection from this investigational vaccine. Financial compensation will be provided.
If you are a healthy adult aged 18-50, we invite you to apply!
Study Background
Researchers at The National Institute of Allergy and Infectious Diseases (NIAID) are conducting a research study of an investigational vaccine that targets influenza (flu).
During this study, we will investigate the safety and tolerability of the investigational product and also study your body’s immune response.
If you’re eligible to participate, you will receive the investigational product two times, you will have 15-18 scheduled clinic visits over a period of 40 weeks. Participants will not get flu infection from this investigational vaccine. Financial compensation will be provided.
If you are a healthy adult aged 18-50, we invite you to apply!
Additional Information
In this research study, want to determine the safety of an investigational flu vaccine (FluMos-v2) and observe how the immune system responds to it.
You may qualify for a study if you meet the following criteria.
Inclusion Criteria:
Healthy adults ages 18-50
Have not received the flu vaccine recently
Have not received the 2023-2024 flu vaccine
Available to visit the clinic for 40 weeks after enrollment
BMI ≤ 35
If female, not pregnant or breastfeeding
Participants can expect this study to last up to 40 weeks. During the study, volunteers will receive the experimental flu vaccine twice via injection into the upper arm muscle, as well as participate in 15-18 scheduled clinic visits and 8-12 telephone calls. At each clinic follow-up visit volunteers will have their blood drawn, and over the course of this study they will be required to get four fine-needle aspirations of the lymph nodes.
Participants may receive up to $5,275 in compensation. Actual compensation depends on the number of visits and procedures completed.
There is no cost for you to participate in our research study.
